Comparison of the Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil vs Valsartan by Ambulatory Blood Pressure Monitoring

J Clin Hypertens (Greenwich). 2011;13:467–472. ©2011 Wiley Periodicals, Inc. Azilsartan medoxomil (AZL‐M) is a unique angiotensin II receptor blocker (ARB) under development for the treatment of hypertension. To compare this ARB with another in the class, the authors studied the effects of AZL‐M and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Hypertens (Greenwich)
Egile Nagusiak: Sica, Domenic, White, William B., Weber, Michael A., Bakris, George L., Perez, Alfonso, Cao, Charlie, Handley, Alison, Kupfer, Stuart
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Publishing Ltd 2011
Gaiak:
Original Papers
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108745/
https://ncbi.nlm.nih.gov/pubmed/21762358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2011.00482.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak